PubRank

Muna I Naash

Author PubWeight™ 58.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci 2004 1.92
2 Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One 2006 1.71
3 Retention of function without normal disc morphogenesis occurs in cone but not rod photoreceptors. J Cell Biol 2006 1.70
4 The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice. Hum Mol Genet 2004 1.48
5 RPE65: role in the visual cycle, human retinal disease, and gene therapy. Ophthalmic Genet 2009 1.39
6 A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles. PLoS One 2009 1.37
7 Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression. Invest Ophthalmol Vis Sci 2004 1.32
8 The Cys214-->Ser mutation in peripherin/rds causes a loss-of-function phenotype in transgenic mice. Biochem J 2005 1.28
9 Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. FASEB J 2009 1.22
10 Effect of Rds abundance on cone outer segment morphogenesis, photoreceptor gene expression, and outer limiting membrane integrity. J Comp Neurol 2007 1.20
11 DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice. J Clin Invest 2012 1.19
12 Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate. Invest Ophthalmol Vis Sci 2007 1.16
13 Differential requirements for retinal degeneration slow intermolecular disulfide-linked oligomerization in rods versus cones. Hum Mol Genet 2008 1.15
14 Outer segment oligomerization of Rds: evidence from mouse models and subcellular fractionation. Biochemistry 2008 1.12
15 P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci 2003 1.10
16 Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina. PLoS One 2009 1.06
17 Role of the second intradiscal loop of peripherin/rds in homo and hetero associations. Biochemistry 2005 1.05
18 The role of Rds in outer segment morphogenesis and human retinal disease. Ophthalmic Genet 2006 1.04
19 Differences in RDS trafficking, assembly and function in cones versus rods: insights from studies of C150S-RDS. Hum Mol Genet 2010 1.03
20 Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci 2013 1.02
21 S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA. Hum Mol Genet 2013 0.97
22 Molecular characterization of the skate peripherin/rds gene: relationship to its orthologues and paralogues. Invest Ophthalmol Vis Sci 2003 0.97
23 Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells. Biomaterials 2011 0.96
24 Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery. PLoS One 2012 0.96
25 Nanoparticles for retinal gene therapy. Prog Retin Eye Res 2010 0.95
26 Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci 2014 0.93
27 Direct gene transfer with compacted DNA nanoparticles in retinal pigment epithelial cells: expression, repeat delivery and lack of toxicity. Nanomedicine (Lond) 2012 0.93
28 Expression profiling after retinal detachment and reattachment: a possible role for aquaporin-0. Invest Ophthalmol Vis Sci 2008 0.92
29 Defects in the outer limiting membrane are associated with rosette development in the Nrl-/- retina. PLoS One 2012 0.92
30 Increased cone sensitivity to ABCA4 deficiency provides insight into macular vision loss in Stargardt's dystrophy. Biochim Biophys Acta 2011 0.91
31 Genetic supplementation of RDS alleviates a loss-of-function phenotype in C214S model of retinitis pigmentosa. Adv Exp Med Biol 2008 0.90
32 Biochemical analysis of phenotypic diversity associated with mutations in codon 244 of the retinal degeneration slow gene. Biochemistry 2010 0.90
33 Late-onset cone photoreceptor degeneration induced by R172W mutation in Rds and partial rescue by gene supplementation. Invest Ophthalmol Vis Sci 2007 0.90
34 Structural and functional relationships between photoreceptor tetraspanins and other superfamily members. Cell Mol Life Sci 2011 0.88
35 Differential distribution of proteins and lipids in detergent-resistant and detergent-soluble domains in rod outer segment plasma membranes and disks. J Neurochem 2007 0.88
36 Absence of functional and structural abnormalities associated with expression of EGFP in the retina. Invest Ophthalmol Vis Sci 2004 0.88
37 Gene therapy for Stargardt disease associated with ABCA4 gene. Adv Exp Med Biol 2014 0.87
38 Nonviral ocular gene therapy: assessment and future directions. Curr Opin Mol Ther 2008 0.85
39 A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium. Biomaterials 2013 0.85
40 Differential developmental deficits in retinal function in the absence of either protein tyrosine sulfotransferase-1 or -2. PLoS One 2012 0.83
41 Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases. J Control Release 2013 0.83
42 RDS in cones does not interact with the beta subunit of the cyclic nucleotide gated channel. Adv Exp Med Biol 2010 0.82
43 Mouse models of human retinal disease caused by expression of mutant rhodopsin. A valuable tool for the assessment of novel gene therapies. Adv Exp Med Biol 2003 0.81
44 Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment. J Biol Chem 2014 0.80
45 A perspective on the role of the extracellular matrix in progressive retinal degenerative disorders. Invest Ophthalmol Vis Sci 2013 0.80
46 Synthesis and characterization of glycol chitosan DNA nanoparticles for retinal gene delivery. ChemMedChem 2013 0.80
47 AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci 2011 0.80
48 Episomal maintenance of S/MAR-containing non-viral vectors for RPE-based diseases. Adv Exp Med Biol 2014 0.79
49 A 350 bp region of the proximal promoter of Rds drives cell-type specific gene expression. Exp Eye Res 2010 0.79
50 The function of oligomerization-incompetent RDS in rods. Adv Exp Med Biol 2010 0.78
51 Focus on molecules: RDS. Exp Eye Res 2009 0.78
52 Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa. Adv Exp Med Biol 2010 0.78
53 Mislocalization of oligomerization-incompetent RDS is associated with mislocalization of cone opsins and cone transducin. Adv Exp Med Biol 2012 0.77
54 Structural characterization of the second intra-discal loop of the photoreceptor tetraspanin RDS. FEBS J 2012 0.77
55 In vitro analysis of ribozyme-mediated knockdown of an ADRP associated rhodopsin mutation. Adv Exp Med Biol 2008 0.76
56 Transgenic animal studies of human retinal disease caused by mutations in peripherin/rds. Adv Exp Med Biol 2006 0.76
57 Overexpression of ROM-1 in the cone-dominant retina. Adv Exp Med Biol 2012 0.75
58 Overexpression of retinal degeneration slow (RDS) protein adversely affects rods in the rd7 model of enhanced S-cone syndrome. PLoS One 2013 0.75
59 Light/dark translocation of alphatransducin in mouse photoreceptor cells expressing G90D mutant opsin. Adv Exp Med Biol 2006 0.75
60 Retinal degenerations: genetics, mechanisms, and therapies. J Ophthalmol 2011 0.75
61 Electrophysiological characterization of rod and cone responses in the baboon nonhuman primate model. Adv Exp Med Biol 2014 0.75